KUMAR NEIL (See Remarks) sold 8.2% of their position (44.98K shares) of BRIDGEBIO PHARMA, INC. on the open market
Open‑market sale worth $3.73M — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
Common Stock
Shares
−1.90K
Price / share
$81.15
Trade value
$154.18K
% of position
Common Stock
Shares
−17.28K
Price / share
$82.21
Trade value
$1.42M
% of position
Common Stock
Shares
−14.60K
Price / share
$82.99
Trade value
$1.21M
% of position
Common Stock
Shares
−1.20K
Price / share
$83.77
Trade value
$100.44K
% of position
Common Stock
Shares
−8.10K
Price / share
$83.86
Trade value
$679.26K
% of position
Common Stock
Shares
−1.80K
Price / share
$84.69
Trade value
$152.44K
% of position
Common Stock
Shares
−100.00
Price / share
$85.65
Trade value
$8.56K
% of position
Net shares
−44.98K
Net value
-$3.73M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/18/2026 | S · Sale | −1.90K | $81.15 | $154.18K | 0.7% | 278.31K | 276.41K |
| Common Stock Direct | 8/18/2026 | S · Sale | −17.28K | $82.21 | $1.42M | 6.3% | 276.41K | 259.13K |
| Common Stock Direct | 8/18/2026 | S · Sale | −14.60K | $82.99 | $1.21M | 5.6% | 259.13K | 244.53K |
| Common Stock Direct | 8/18/2026 | S · Sale | −1.20K | $83.77 | $100.44K | 0.5% | 244.53K | 243.33K |
| Common Stock Indirect | 8/19/2026 | S · Sale | −8.10K | $83.86 | $679.26K | 1.6% | 515.69K | 507.59K |
| Common Stock Indirect | 8/19/2026 | S · Sale | −1.80K | $84.69 | $152.44K | 0.4% | 507.59K | 505.79K |
| Common Stock Indirect | 8/19/2026 | S · Sale | −100.00 | $85.65 | $8.56K | 0.0% | 505.79K | 505.69K |
| Total | −44.98K | -$3.73M | ||||||
Common Stock
IndirectCommon Stock
Indirect| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 3.57M | Indirect |
| Common Stock | 750K | Indirect |
| Total | 4.32M | 4.32M indirect |